HEPHAISTOS-PHARMA

hephaistos-pharma-logo

HEPHAISTOS-Pharma is a biotechnology startup developing anti-tumor immunotherapies.

#SimilarOrganizations #People #Financial #Website #More

HEPHAISTOS-PHARMA

Social Links:

Industry:
Biotechnology

Founded:
2018-01-01

Address:
Orsay, Ile-de-France, France

Country:
France

Website Url:
http://www.hephaistos-pharma.fr

Total Employee:
1+

Status:
Active

Total Funding:
71.43 K EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Apache Wordpress Plugins IPv6 PHP


Similar Organizations

lytica-therapeutics-logo

Lytica Therapeutics

Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics.


Current Advisors List

martine-caroff_image

Martine Caroff Chairwoman @ HEPHAISTOS-Pharma
Board_member

Current Employees Featured

frederic-caroff_image

Frederic Caroff
Frederic Caroff CEO @ HEPHAISTOS-Pharma
CEO
2018-07-01

martine-caroff_image

Martine Caroff
Martine Caroff CSO @ HEPHAISTOS-Pharma
CSO

Founder


martine-caroff_image

Martine Caroff

Investors List

easme_image

EASME - EU Executive Agency for SMEs

EASME - EU Executive Agency for SMEs investment in Grant - HEPHAISTOS-Pharma

Official Site Inspections

http://www.hephaistos-pharma.fr

  • Host name: webacc6.sd5.ghst.net
  • IP address: 155.133.138.8
  • Location: Poland
  • Latitude: 52.2394
  • Longitude: 21.0362
  • Timezone: Europe/Warsaw

Loading ...

More informations about "HEPHAISTOS-Pharma"

Homepage - HEPHAISTOS-Pharma

HEPHAISTOS-Pharma accueille Elaia à son capital pour développer des traitements plus puissants contre le cancer. 16 May 2024. L’ECHO.BE: La biotech HEPHAISTOS va s’appuyer …See details»

HEPHAISTOS PHARMA - Pulsalys

HEPHAISTOS-Pharma travaille sur plusieurs modèles de tumeurs : les lymphomes, pour lesquels un taux de réponse de 70% est obtenu avec la combinaison, et les ostéosarcomes, sur lesquels aucun traitement ne …See details»

HEPHAISTOS-Pharma - LinkedIn

Lyon, Auvergne-Rhône-Alpes 69007, FR ... HEPHAISTOS-Pharma est une startup en biotechnologie développant des immunothérapies anti-tumorales permettant de révolutionner les traitements contre ...See details»

HEPHAISTOS-Pharma - OncoSTART

Presentation A preclinical stage Biotech company developing the next generation of oncology treatments that will be boost immune system to treat incurable cancers and potentialize Immune Checkpoint Inhibitors. Contact …See details»

HEPHAISTOS-Pharma - Crunchbase Company Profile

Hephaistos-pharma.fr/ 44,229; Highlights. obfuscated. Total Funding Amount . Unlock for free . Employee Profiles 2. Investors 10. Similar Companies 8. …See details»

☑️HEPHAISTOS-Pharma — Consulting Organization from France, …

HEPHAISTOS-Pharma — Consulting Organization from France, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Laboratory & Measurement sectors.See details»

HEPHAISTOS-PHARMA - VentureRadar

HEPHAISTOS-Pharma is a biotechnology company involved in the development of next-generation immunotherapies against cancer. Their main focus is on industrializing their …See details»

HEPHAISTOS-Pharma - Company Profile

HEPHAISTOS-Pharma. HEPHAISTOS-Pharma est une startup en biotechnologie développant des immunothérapies anti-tumorales permettant de révolutionner les traitements contre le …See details»

HEPHAISTOS-Pharma - Lyon Ingenierie Template - systinn-rhu.fr

HEPHAISTOS is a Franco-Belgian company specializing in immunotherapy, dedicated to designing and developing “Immune Sensor Modulators” (ISM) to address a major challenge in …See details»

Homepage - HEPHAISTOS-Pharma

HEPHAISTOS-Pharma has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 868937. HEPHAISTOS-Pharma’s academic partner CRCL has received funding from …See details»

HEPHAISTOS-PHARMA (ORSAY) Chiffre d'affaires, résultat, bilans …

HEPHAISTOS-PHARMA, société par actions simplifiée, au capital social de 75953,00 EURO, dont le siège social est situé au 21 RUE JEAN ROSTAND, 91400 ORSAY, immatriculée au …See details»

HEPHAISTOS-Pharma: Contact Details and Business Profile

HEPHAISTOS-Pharma est une startup en biotechnologie développant des immunothérapies anti-tumorales permettant de révolutionner les traitements contre le cancer en décuplant l'efficacité …See details»

HEPHAISTOS-Pharma Company Information - Funding, Investors, …

See HEPHAISTOS-Pharma company profile and funding data. Mentioned on: FEATURED IN. Startups Discover startups. Startup Rankings. Discover the fastest growing tech startups …See details»

HEPHAISTOS-Pharma Company Profile - Office Locations ... - Craft

HEPHAISTOS-Pharma has 5 employees at their 1 location. See insights on HEPHAISTOS-Pharma including office locations, competitors, revenue, financials, executives, subsidiaries …See details»

Société HEPHAISTOS-PHARMA : Chiffre d'affaires, statuts

Les déclarations de comptes de HEPHAISTOS-PHARMA nous permettent de déduire que son chiffre d'affaires était inférieur à 700 000 € ou que son bilan était inférieur à 350 000 € en …See details»

Hephaitos Pharma - VentureRadar

HEPHAISTOS-PHARMA France Privately Held HEPHAISTOS-Pharma is a biotechnology company involved in the development of next-generation immunotherapies against cancer. …See details»

HEPHAISTOS-Pharma – Elaia

HEPHAISTOS-Pharma, a biotechnology company developing next generation immunotherapies against cancer targeting innate immunity to increase the cure rate of patients, has completed …See details»

HEPHAISTOS-Pharma - EU-Startups

Articles about HEPHAISTOS-Pharma: May 17, 2024 Weekly funding round-up! All of the European startup funding rounds we tracked this week (May 13 – May 17) May 16, 2024 …See details»

HEPHAISTOS-Pharma - Overview, News & Similar companies

Jan 23, 2024 View HEPHAISTOS-Pharma (www.hephaistos-pharma.fr) location in Ile-de-France, France , revenue, industry and description. ... HEPHAISTOS-Pharma is a preclinical …See details»

French biotech startup HEPHAISTOS secures €10.3m seed round …

May 23, 2024 HEPHAISTOS’ innovative approach to innate modulation has received significant validation and support from prestigious programs, with a total of €5.8 million awarded to …See details»

linkstock.net © 2022. All rights reserved